A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial (Q46708832)
Jump to navigation
Jump to search
scientific article published in September 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial |
scientific article published in September 2005 |
Statements
1 reference
A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial (English)
1 reference
1 reference
1 reference
1 reference
1 reference
Steven R Steinhubl
1 reference
Gilles Montalescot
1 reference
Deepak L Bhatt
1 reference
Peter B Berger
1 reference
S Claiborne Johnston
1 reference
Eric A Cohen
1 reference
Steven M Haffner
1 reference
William E Boden
1 reference
Keith A Fox
1 reference
Werner Hacke
1 reference
Henry R Black
1 reference
Mark A Creager
1 reference
J Donald Easton
1 reference
Marcus D Flather
1 reference
Christian W Hamm
1 reference
Koon-Hou Mak
1 reference
Jean-Louis Mas
1 reference
Thomas A Pearson
1 reference
Michael A Weber
1 reference
Joan Booth
1 reference
CHARISMA Investigators
1 reference
1 September 2005
1 reference
1 reference
150
1 reference
3
1 reference
401
1 reference
Identifiers
1 reference
1 reference